Verici Dx Postpones ‘Tutivia’ Revenue as Medicare Approval Drags On

Highlights:,CMS Coverage Delay,: Verici Dx’s Tutivia test faces a delay in Medicare approval, pushing revenue recognition to 2025.,Financial Stability...

SkinBioTherapeutics Acquires Bio-Tech Solutions Ltd for £1.25 Millio...

Highlights,SkinBioTherapeutics has acquired Bio-Tech Solutions Ltd for £1.25 million.,The deal will be financed through a combination of a £950,000 lo...

ProBiotix Health Enters New Partnership with Mexico-Based Raff

Key Points:,Strategic Partnership,: ProBiotix teams up with Raff, a key player in the Mexican dairy and nutraceutical sectors.,Market Potential,: Mexi...

Avacta Group Presents Breakthrough Preclinical Data on Pre|CISION™ P...

Key Points:,AVA6103,, a new peptide drug conjugate (PDC), targets Topoisomerase I inhibitors to tumor cells, reducing toxicity to healthy tissues and...

GSK Reaches $2.2bn Settlement in Zantac Litigation in the United Sta...

Highlights:,GSK PLC has agreed to pay up to $2.2 billion to settle approximately 80,000 US lawsuits related to its heartburn medication, Zantac.,The s...

FTSE 100 Highlights: Gains Lost; GSK Sees Increase on $2.2bn Zantac...

Highlights:,Vistry Group PLC faced significant losses, becoming one of the FTSE 100's biggest fallers after a profit warning.,GSK PLC shares surged on...

A positive outcome from the AGM has prompted a rise in the shares of...

Highlights:,Fusion Antibodies PLC reports significant revenue growth, with expected first-half revenues reaching £1.2 million, more than double the pr...

ProBiotix Health Shares Q3 2024 Trading Update with Continued Growth...

Highlights,ProBiotix reported a 39% increase in sales, reaching £1.525 million compared to £1.099 million in 2023.,A product launch on Amazon and in 2...

AstraZeneca has acquired a license from CSPC in China for a choleste...

Highlights:,AstraZeneca has acquired a license for a novel cholesterol-lowering drug, YS2302018, from CSPC Pharmaceutical for an initial payment of $1...

Futura Medical Secures $5 Million Milestone Payment Following US Lau...

Highlights:,Milestone Payment Secured,: Futura Medical received a $5 million payment following the US launch of its over-the-counter erectile dysfunct...

ValiRx Subsidiary Partners with BioRep to Enhance Drug Screening Ser...

Key Points:,Inaphaea BioLabs has executed a co-marketing agreement with BioRep to enhance drug screening services and patient-derived cells.,BioRep wi...

Faron Pharmaceuticals to Host Capital Markets Day on 22 October 2024...

Key Points:,Faron Pharmaceuticals will host a Capital Markets Day on October 22, 2024, featuring key presentations from leading experts.,The agenda in...

Life Science REIT Backed by Berenberg's Optimistic Forecast, UK Grow...

Highlights:,Strong growth potential:,Berenberg reaffirms its "buy" rating for Life Science REIT, highlighting a price target of 57p per share.,Underva...

China and Southeast Asia Hurdles Lead to Revenue Warning from Eco An...

Highlights:,Eco Animal Health warns full-year revenues will fall below expectations due to challenges in China and Southeast Asia.,Strong performance...

Haleon (LSE:HLN) shares update on off-market transaction with Pfizer

Haleon plc (LSE:HLN) has announced that it will purchase 60,526,315 ordinary shares from Pfizer Inc. as part of an off-market transaction. This agreem...

Creo Medical Secures £12 Million to Fuel Growth and Target Break-Eve...

Highlights,Creo Medical Group PLC successfully raises £12 million through a share placement to support growth.,Additional stock offerings could genera...

FTSE 100 Live: London Shares Poised for Uptick Ahead of Key Economic...

Highlights,Haleon PLC completes a share repurchase agreement with Pfizer Inc, totaling £230 million.,The transaction concludes Haleon’s £500 million s...

Haleon Acquires Shares as Pfizer Reduces Its Position

Highlights,Haleon PLC completes a significant share repurchase from Pfizer Inc.,The transaction concludes a £500 million share buyback program initiat...

Celadon Pharmaceuticals Announces CFO Jonathan Turner’s Departure

Highlights:,Celadon Pharmaceuticals announced CFO Jonathan Turner will step down from his position on 27 December.,The company has begun the search fo...

Ondine Biomedical (LSE:OBI) records 101% jump in revenue in 1HFY24,...

Ondine Biomedical Inc. (LSE:OBI),, a prominent provider of light-activated antimicrobial technology aimed at preventing and treating hospital infectio...